Lv4
470 积分 2021-10-12 加入
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
1天前
待确认
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
2个月前
已完结
Multicomponent Synthesis of Imidazole-Based Ionizable Lipids for Highly Efficient and Spleen-Selective Messenger RNA Delivery
3个月前
已完结
Novel Lipid Nanoparticle (LNP) Delivery Systems Enabling the Advancement of RNA Therapeutics
3个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
4个月前
已完结
Chemical Design Strategy of Ionizable Lipids for In Vivo mRNA Delivery
5个月前
已完结
Measurement and clinical interpretation of CRISPR off-targets
6个月前
已完结
Cm-siRPred: Predicting chemically modified siRNA efficiency based on multi-view learning strategy
6个月前
已完结
皖公网安备34019202002308
